Ownership of Corporate Names. Each Party shall retain all right, title and interest in and to any corporate names, Trademarks and logos owned or otherwise used by such Party or any of its Affiliates.
Ownership of Corporate Names. As between the Parties, Licensor shall retain all right, title and interest in and to its Corporate Names.
Ownership of Corporate Names. As between the Parties, each Party shall retain all right, title and interest in and to its Corporate Names and agrees that it shall not attack, dispute or contest the validity of or ownership of such other Party’s Corporate Names or any registrations issued or issuing with respect thereto. Each Party expressly acknowledges and agrees that no ownership rights are vested or created by the limited rights of use granted pursuant to Section 5.1.5 or 5.6 and that all use of the Corporate Names in accordance therewith, including any goodwill generated in connection therewith, inures to the benefit of the respective owner of the Corporate Names and the owner of such Corporate Names may call for a confirmatory assignment thereof.
Ownership of Corporate Names. As between the Parties, each Party shall retain all right, title and interest in and to its corporate names and logos, and any goodwill derived through the use of such marks shall inure solely to the benefit of its owner. Neither Party shall, without the other Party’s prior written consent, use any Trademarks of the other Party (including the other Party’s corporate name and logo), or marks confusingly similar thereto, in connection with such Party’s marketing or promotion of Products under this Agreement, except as expressly provided in, and in accordance with, this Agreement.
Ownership of Corporate Names. Pharmacyclics shall retain all right, title and interest in and to any corporate names, Trademarks and logos owned or otherwise used by Pharmacyclics or any of its Affiliates. As of the Effective Date, Pharmacyclics has not chosen or used any Trademark for the Licensed Compound or Licensed Products. Xynomic shall have sole discretion in selecting and using and own any Trademarks for the Licensed Compound and Licensed Products (subject to Section 10.6.1(e) and Section 10.7(e)).
Ownership of Corporate Names. As between the Parties, Xxxxxxx shall retain all right, title and interest in and to its Corporate Names.
Ownership of Corporate Names. As between the Parties, Caribou shall retain all right, title, and interest in and to its Corporate Names.
Ownership of Corporate Names. As between the Parties, Lexicon shall retain all right, title and interest in and to its Corporate Names.
Ownership of Corporate Names. Subject to Section 9.4, as between the Parties, BioNTech shall retain all right, title and interest in and to its Corporate Names, and Genentech shall retain all right, title and interest in and to its Corporate Names.
Ownership of Corporate Names. As between the Parties, Licensor shall retain all right, title and interest in and to its Corporate Names. *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a confidential treatment request.
